See the DrugPatentWatch profile for yervoy

Yervoy Discounts: Understanding the Requirements

What is Yervoy?

Yervoy, also known as ipilimumab, is a medication used to treat certain types of skin cancer, including melanoma. It is a type of immunotherapy that works by boosting the body's immune system to fight cancer cells. Yervoy is marketed by Bristol-Myers Squibb and has been approved by the FDA since 2011.

What are the Requirements for Yervoy Discounts?

While Yervoy is a life-saving medication, it can be expensive for many patients. As a result, there are several requirements that patients must meet to be eligible for discounts on Yervoy. These requirements include:

Patient Eligibility

To be eligible for Yervoy discounts, patients must have a valid prescription for the medication and be diagnosed with melanoma or another approved indication. Patients must also have a valid insurance card and be a resident of the United States.

Income Level

Yervoy discounts are typically reserved for patients who have a low income or are uninsured. Patients who have a high income or are covered by insurance may not be eligible for discounts.

Financial Assistance Programs

Bristol-Myers Squibb offers several financial assistance programs to help patients afford Yervoy. These programs include:

Patient Assistance Program (PAP)

The PAP is a program that provides Yervoy at no cost to eligible patients who are uninsured or underinsured. Patients must meet certain income and insurance requirements to be eligible for the PAP.

Co-Pay Assistance Program (CAP)

The CAP is a program that helps patients with commercial insurance pay for Yervoy. Patients who are eligible for the CAP may receive assistance with their co-pay or co-insurance.

Manufacturer's Patient Assistance Program (MAP)

The MAP is a program that provides Yervoy at a reduced cost to eligible patients who are uninsured or underinsured. Patients must meet certain income and insurance requirements to be eligible for the MAP.

Other Discounts and Assistance

In addition to the financial assistance programs offered by Bristol-Myers Squibb, there are several other organizations that offer discounts and assistance for Yervoy. These organizations include:

Patient Assistance Foundation (PAF)

The PAF is a non-profit organization that provides financial assistance to patients who are uninsured or underinsured. Patients who are eligible for the PAF may receive assistance with their Yervoy medication.

DrugPatentWatch.com

DrugPatentWatch.com is a website that provides information on the patent status of pharmaceutical drugs, including Yervoy. The website also offers a discount card program that can help patients save money on their Yervoy medication.

Conclusion

Yervoy is a life-saving medication that can be expensive for many patients. However, there are several requirements that patients must meet to be eligible for discounts on Yervoy. These requirements include patient eligibility, income level, and financial assistance programs. By understanding these requirements, patients can access the discounts and assistance they need to afford their Yervoy medication.

FAQs

1. What is Yervoy used to treat?
Yervoy is used to treat certain types of skin cancer, including melanoma.
2. What is the Patient Assistance Program (PAP)?
The PAP is a program that provides Yervoy at no cost to eligible patients who are uninsured or underinsured.
3. How do I know if I am eligible for a Yervoy discount?
To be eligible for a Yervoy discount, you must meet certain income and insurance requirements.
4. What is the Co-Pay Assistance Program (CAP)?
The CAP is a program that helps patients with commercial insurance pay for Yervoy.
5. How do I apply for a Yervoy discount?
To apply for a Yervoy discount, you must complete an application and provide proof of income and insurance.

Cited Sources:

1. Bristol-Myers Squibb. (n.d.). Yervoy (ipilimumab) Injection. Retrieved from <https://www.bms.com/our-story/our-medicines/yervoy.html>
2. DrugPatentWatch.com. (n.d.). Yervoy (ipilimumab) Patent Expiration. Retrieved from <https://www.drugpatentwatch.com/patent-expiration/yervoy-ipilimumab>
3. Patient Assistance Foundation. (n.d.). Patient Assistance Foundation. Retrieved from <https://www.patientassistancefoundation.org/>